IP Library Granted Patent US 7,022,529
Granted Patent B2
US 7,022,529 · App. 10/745,972 · Granted Apr 4, 2006

Particles for diagnostic and therapeutic use

Assignee: Dade Behring Marburg GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,022,529
App. No.
10/745,972
Granted
Apr 4, 2006
Kind
B2
Abstract

Methods, compositions and kits are disclosed. The compositions are light emitting and comprise a polymeric matrix having dissolved therein a photoactive compound. The composition has the characteristic that, after activation of the photoactive compound, the rate of decrease in the intensity of light emission at any time during a 20-fold decrease in the intensity is proportional to the intensity of the light emission. In one embodiment the polymeric matrix is comprised of particles of about 20 nm to about 100 μm in diameter to which is bound a specific binding pair member. The particles generally comprise a polymeric matrix having dissolved therein about 1 to about 20% by weight of a dopant. The compositions may be used in methods for determining an analyte. A combination is provided comprising (1) a medium suspected of containing the analyte, (2) and the aforementioned composition. The photoactive substance is activated and the effect of the activating on the optical properties of the combination is detected. The presence and amount of the effect is related to the presence and amount of the analyte in the medium. Also disclosed are kits for use in an assay.

Claims (12)

1. A method for determining the presence or amount of an analyte, said method comprising:

(a) providing in combination (1) a medium suspected of containing said analyte, and (2) a first specific binding pair (sbp) member capable of binding to said analyte or to a second sbp member to form a complex related to the presence of said analyte, wherein at least one of said sbp members is bound to polymeric particles of about 20 nm to about 100 μm in diameter having homogeneously dispersed therein about 1 to about 20 weight percent of a dopant, which is a plasticizer selected from the group consisting of higher alkylaromatic compounds and higher alkyloxyaromatic compounds and fluorocarbons, a photosensitizer and a chemiluminescent substance,

(b) activating said chemiluminescent substance and

(c) determining the effect of said activating on the optical properties of said combination, the magnitude of said effect being related to the presence or amount of said analyte in said medium.

2. The method of claim 1 wherein said first sbp member is associated with said particles.

3. The method of claim 1 wherein said combination comprises said second sbp member associated with said particles.

4. The method of claim 1 wherein said photosensitizer is incorporated into a second set of particles associated with one of said sbp members.

5. The method of claim 4 wherein said second set of particles comprises a dopant.

6. The method of claim 1 wherein said polymeric particles comprise a polymer selected from the group consisting of polystyrenes, polyvinyl chlorides and polyvinylnaphthalenes.

7. A method for determining the presence or amount of an analyte, said method comprising:

(a) combining a sample suspected of containing said analyte with polymeric particles of 20 nm to 100 μm in diameter having dissolved therein (a) 2 to 10% by weight of a dopant, which is a plasticizer selected from the group consisting of higher alkylaromatic compounds and higher alkyloxyaromatic compounds and fluorocarbons, (b) a photosensitizer and (c) a chemiluminescent substance and reagents that produce a color change in relation to the amount of said analyte and

(b) activating said photoactive substance and relating the intensity of the light emitted to the amount of said color change, the amount thereof being related to the presence or amount of said analyte.

Assignments (1)
CHANGE OF NAME Recorded Feb 11, 2010
From: DADE BEHRING MARBURG GMBH
To: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
Reel/Frame 023915/0821 →
Continuity (2)
Division 0946506500 · Dec 15, 1999
Related Publication 20040241711A1 · Dec 2, 2004